Data Charting Relevant information from each included study was extracted using a data charting form that captured the following fields: author(s), year of publication, country of origin, whether the combination was an add-on or simultaneously used, study population characteristics relevant to the outcomes, and sample size, study design, intervention or exposition type and details of these, comparator, outcomes and their specifics, adverse effects reports, and key findings related to the scoping review questions
The GLP-1s weight loss program is not suitable for all individuals
It activates both GIP and GLP-1 receptors, which together regulate appetite, metabolism, and blood sugar more effectively than medications that focus on a single hormone
For more information visit Asset & Logo Licensing